Diversified Trust CO Organon & Co. Transaction History

Diversified Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$18.65 - $23.03 $405,861 - $501,178	21,762 New	21,762 $416,000
Q2 2023 Jul 18, 2023	BUY	$19.27 - $24.63 $270,936 - $346,297	14,060 New	14,060 $292,000
Q2 2022 Jul 12, 2022	SELL	$31.66 - $38.9 $457,961 - $562,688	-14,465 Closed	0 $0
Q1 2022 Apr 07, 2022	BUY	$30.45 - $39.36 $204,502 - $264,341	6,716 Added 86.67%	14,465 $505,000
Q4 2021 Jan 13, 2022	SELL	$28.67 - $37.13 $104,014 - $134,707	-3,628 Reduced 31.89%	7,749 $236,000
Q3 2021 Jan 13, 2022	BUY	$28.63 - $35.64 $325,723 - $405,476	11,377 New	11,377 $373,000

793

204M

1.71M

870K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.72B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.